Angus J A, Black J W
Br J Pharmacol. 1979 Sep;67(1):59-65.
1 In the isolated, lumen-perfused, stomach preparation of the mouse, metiamide was found by kinetic analysis to behave like a simple competitive antagonist of histamine-stimulated acid secretion. However, the pK(B) estimate of 5.08 was significantly lower than that found in guinea-pig atrium (6.0) or rat uterus (6.1) suggesting that H(2)-receptors might not be homogeneous.2 A similar analysis showed that atropine also behaved like a simple competitive antagonist of bethanechol-stimulated acid secretion and the estimated pK(B) (7.65) was significantly lower than the standard estimate of this parameter in guinea-pig ileum (9.0). Either the muscarinic cholinoceptors in mouse stomach were also anomalous or the preparation was introducing a systematic error. Lumen perfusion might distort this type of kinetic analysis by allowing steady-state conditions but not true equilibrium to develop at the receptor compartment due to loss of antagonist into the gastric secretion. Drug interactions at receptors in the muscle layers of the stomach would be expected to be much less sensitive to this error.3 When the atropine-bethanechol interaction was measured on the contraction of the isolated, lumen-perfused, stomach of the mouse the necessary conditions for simple competition were not met even though the sensitivity to atropine was obviously increased. The criteria for the expected simple competition were being obscured by events at low antagonist concentrations. Alterations in agonist or antagonist concentrations could be more or less eliminated so that physiological antagonism, perhaps by release of 5-hydroxytryptamine, was considered. This was supported, to some extent, by finding that, when stomachs from animals pretreated with reserpine were used, the kinetic analysis was normalized and gave a pK(B) of 8.99. Apparently, the muscarinic receptors in mouse stomach are homogeneous with those in other tissues.4 Therefore, we conclude that our results no more point to heterogeneity among histamine receptors than they point to differences in muscarinic cholinoceptors because this type of kinetic analysis can be readily distorted by special features of the measuring system.
在小鼠离体、管腔内灌注的胃制备模型中,通过动力学分析发现甲硫咪特表现为组胺刺激胃酸分泌的简单竞争性拮抗剂。然而,其5.08的pK(B)估计值显著低于豚鼠心房(6.0)或大鼠子宫(6.1)中的值,这表明H(2)受体可能并非同质。
类似的分析表明,阿托品也表现为氨甲酰甲胆碱刺激胃酸分泌的简单竞争性拮抗剂,其估计的pK(B)(7.65)显著低于豚鼠回肠中该参数的标准估计值(9.0)。要么小鼠胃中的毒蕈碱型胆碱受体也异常,要么该制备模型引入了系统误差。管腔内灌注可能会使这种动力学分析失真,因为尽管能达到稳态条件,但由于拮抗剂进入胃分泌液,受体部位无法达到真正的平衡。预计胃肌层中受体的药物相互作用对这种误差的敏感性要低得多。
当在小鼠离体、管腔内灌注的胃收缩实验中测量阿托品 - 氨甲酰甲胆碱相互作用时,即使对阿托品的敏感性明显增加,也未满足简单竞争的必要条件。低拮抗剂浓度下的事件掩盖了预期简单竞争的标准。激动剂或拮抗剂浓度的变化或多或少可以消除,因此考虑了生理拮抗作用,可能是通过5 - 羟色胺的释放。在某种程度上,这一观点得到了支持,因为发现使用经利血平预处理动物的胃时,动力学分析正常化,pK(B)为8.99。显然,小鼠胃中的毒蕈碱受体与其他组织中的是同质的。
因此,我们得出结论,我们的结果并不比毒蕈碱型胆碱受体的差异更能表明组胺受体的异质性,因为这种类型的动力学分析很容易因测量系统的特殊特征而失真。